Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn about a recent article he and his colleagues co-authored, published in JACC: Advances, adding:
“How do we predict recurrence post Left Ventricular Thrombus ( LVT ) resoultion?
Echo at the time of LVT resolution preditctive than the time of Diagnosis
After LVT resolution, patient with left ventricular aneurysm (LVA) remained at high risk of recurrence regardless of anticoagulation status, with recurrence rates approaching 50–70% (Figure 1).
Stopping oral anticoagulation (OAC) after LVT resolution increased recurrence risk even in patients without LVA, rising to 19%(Figure 2).
Risk stratification combining LVA status and OAC use revealed a clear gradient of recurrence risk (Figure 3):
Without LVA and receiving OAC: 5/113 (4%)
Without LVA and not receiving OAC: 22/116 (19%)
With LVA and receiving OAC: 4/13 (31%)
With LVA and not receiving OAC: 5/10 (50%)
Highest recurrence: Patients with LVA who were not receiving OAC
Lowest recurrence: Patients without LVA who were receiving OAC
The key question:
If recurrence risk remains elevated across all groups, who can truly stop OAC after LVT resolution?
Stay tunned for Mayo LVT part 3″
Title: Clinical and Echocardiographic Factors Associated With Left Ventricular Thrombus Recurrence
Authors: Kirsten M. Lipps, Hossam Elbenawi, Samuel Heller Jr., Robert D. McBane, Waldemar E. Wysokinski, Ana I. Casanegra, Stanislav Henkin, Thom W. Rooke, Paul W. Wennberg, David A. Liedl, Raymond C. Shields, Damon E. Houghton

Other posts featuring Hossam El Benawi on Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics